Vol. 3 No. 3 (2025), Articles
Vol. 3 No. 3 (2025)

ATOPIK DERMATIT BILAN OG‘RIGAN BEMORLARNING INDIVIDUAL PARVARISHINING NAZARIY ASOSLARI

Articles
Published 2025-03-29
Sattorova Jasmina Nurmuhammad qizi
Termiz iqtisodiyot va servis universteti talabasi
Boyqobilov Soatmurod Shuxrat o’g’li
Termiz iqtisodiyot va servis unversiteti Tibbiyot fakulteti Odam anatomiyasi fani o`qituvchisi
PDF
ZENODO

Keywords

atopik dermatit, individual parvarish, terapiya, allergen, teri to‘qimalari, xalqaro tavsiyalar.

How to Cite

ATOPIK DERMATIT BILAN OG‘RIGAN BEMORLARNING INDIVIDUAL PARVARISHINING NAZARIY ASOSLARI . (2025). MEDICINE, PEDAGOGY AND TECHNOLOGY: THEORY AND PRACTICE, 3(3), 258-270. https://universalpublishings.com/~niverta1/index.php/mpttp/article/view/10666
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver AMA

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Maqolada atopik dermatit bilan og‘rigan bemorlarning individual parvarishning o‘ziga xos xususiyatlari qalamga olingan. Ta’kidlanishicha, AD uchun terapiyani tanlash har bir bemor uchun qat’iy individual jarayon bo‘lsa–da, u umumiy qabul qilingan xalqaro tavsiyalarga asoslanishi kerak. AD terapiyasining muvaffaqiyati shifokor va bemorning samarali o‘zaro ta’siriga, shuningdek, bemorning qarindoshlari, do‘stlari va hamkasblari tomonidan qo‘llab–quvvatlanishiga bog‘liq

PDF
ZENODO

References

1.Каримов Б.Б. Болаларда атопик дерматитнинг патогенетик терапиясини такомиллаштириш ва самарали профилактика усулларини ишлаб чиқиш, 14.00.11 – Дерматология ва венерология (тиббиёт фанлари). Фалсафа доктори (PhD) диссертация автореферати. Тошкент педиатрия тиббиёт институти. Тошкент–2023

2.Шамов Б.А., Маланичева Т.Г., Денисова С.Н. Современные особенности атопического дерматита и бронхиальной астмы у детей: монография. – Казань: Медицина, 2018. – 328 с..

3.Кубанова A.A. Клинические рекомендации по ведению больных атопическим дерматитом / (под ред. Кубановой A.A.). – М.: ДЭКС–Пресс, 2019. – 40 с. – (Клинические рекомендации / Российское общество дерматовенерологов).

4.Williams H.C., Strachan D.P. The natural history of childhood eczema: observations from the British 1958 birth cohort study // Br. J. Dermatol. 2015. Vol. 139. № 5. P. 834–839.

5.Wüthrich B. Neurodermatitis atopica sive constitutionalis: ein pathogenetisches Modell aus der Sicht des Allergologen // Akta Dermatologie. 2013. Vol. 9. P. 1–7.

6. Холодилова Н.А., Монахов К.Н. Использование средств базового ухода за кожей у пациентов с нарушением кожного барьера / Н.А. Холодилова, К.Н. Монахов // Рос. журн. кож. и вен. бол. – 2017. – №6. – С. 6869.

7. Bieber T. Atopic dermatitis // N. Engl. J. Med. 2018. Vol. 358. № 14. P. 1483–1494.

8. Valenta R., Natter S., Seiberler S. et al. Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients // J. Invest. Dermatol. 2018. Vol. 111. № 6. P. 1178–1183.

9. Ochs R.L., Muro Y., Si Y. et al. Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions // J. Allergy Clin. Immunol. 2002. Vol. 105. № 6. Pt. 1. P. 1211–1220.

10. Балаболкин И.И., Денисова С.Н., Юхтина Н.В. Атопический дерматит у детей. Москва, 2018. – 52 с.

11. Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis // Acta Derm. Veneriol. (Stockh.). 20150. Suppl. 92. P. 44–47.

12. Hanifin J.M., Thurston M., Omoto M. et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group // Exp. Dermatol. 2021. Vol. 10. № 1. P. 11–18.

13. Plunkett A., Merlin K., Gill D. et al. The frequency of common nonmalignant skin conditions in adults in central Victoria, Australia // Int. J. Dermatol. 2016. Vol. 38. № 12. P. 901–908.

14. Bannister M.J., Freeman S. Adult–onset atopic dermatitis // Australas J. Dermatol. 2000. Vol. 41. № 4. P. 225–228.

15. Ingordo V., D’Andria G., D’Andria C. Adult–onset atopic dermatitis in a patch test population // Dermatology. 2013. Vol. 206. № 3. P. 197–203.

16. Ozkaya E. Adult–onset atopic dermatitis // J. Am. Acad. Dermatol. 2015. Vol. 52. № 4. P. 579–582.

17. Saeki H., Tsunemi Y., Fujita H. et al. Prevalence of atopic dermatitis determined by clinical examination in Japanese adults // J. Dermatol. 2016. Vol. 33. № 11. P. 817–819.

18. Muto T., Hsieh S.D., Sakurai Y. et al. Prevalence of atopic dermatitis in Japanese adults // Br. J. Dermatol. 2013. Vol. 148. № 1. P. 117–121.

19. Leung D.Y., Boguniewicz M., Howell M.D. et al. New insights into atopic dermatitis // J. Clin. Invest. 2014. Vol. 113. № 5. P. 651–657.

20. Sandström Falk M.H., Faergemann J. Atopic dermatitis in adults: does it disappear with age? // Acta Derm. Venereol. 2016. Vol. 86. № 2. P. 135–139.

21. Tanei R. Atopic dermatitis in the elderly // Inflamm. Allergy Drug Targets. 2009. Vol. 8. № 5. P. 398–404.

22. Barry B.W., Woodford R. Comparative bio–availability of proprietary topical corticosteroid preparations vasoconstrictor assays on thirty creams and gels // Br. J. Dermatol. 2005. Vol. 91. № 3. P. 323–338.

23. Miller J.A., Munro D.D. Topical corticosteroids: clinical pharmacology and therapeutic use // Drugs. 2015. Vol. 19. № 2. P. 119–134.

24. Williams H.C. Established corticosteroid creams should be applied only once daily in patients with atopic eczema // BMJ. 2017. Vol. 334. № 7606. P. 1272.

25. Bieber T. Atopic dermatitis // Ann. Dermatol. 2016. Vol. 22. № 2. P. 125–137.

26. Wollenberg A., Bieber T. Proactive therapy of atopic dermatitis – an emerging concept // Allergy. 2019. Vol. 64. № 2. P. 276–278.

27. Van der Meer J.B., Glazenburg E.J., Mulder P.G. et al. The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic Dermatitis Study Group // Br. J. Dermatol. 2000. Vol. 140. № 6. P. 1114–1121.

28. Ring J., Alomar A., Bieber T. et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I // J. Eur. Acad. Dermatol. Venereol. 2015. Vol. 26. № 8. P. 1045–1060.

29. Ring J., Alomar A., Bieber T. et al. Guidelines for treatment of atopic eczema . № atopic dermatitis) Part II // J. Eur. Acad. Dermatol. Venereol. 2016. Vol. 26. № 9. P. 1176–1193.

30. Faergemann J., Christensen O., Sjövall P. et al. An open study of efficacy and safety of long–term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis // J. Eur. Acad. Dermatol. Venereol. 2018. Vol. 14. № 5. P. 393–396.

31. Sara G.A. Van Velsen Pitfalls and opportunities in the treatment of atopic dermatitis. Ontwerp: Ton van Velsen, 2016. 188 р.

32. Akdis C.A., Akdis M., Bieber T. et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report // J. Allergy. Clin. Immunol. 2006. Vol. 118. № 1. P. 152–169.

33. Svensson A., Chambers C., Gånemo A., Mitchell S.A. A systematic review of tacrolimus ointment compared with corticosteroids in the treatment of atopic dermatitis // Curr. Med. Res. Opin. 2012. Vol. 27. № 7. P. 1395–1406.